Nature Digital Medicine has published a peer-reviewed article co-authored by BENZAIT CEO Ralph Whalen and AI Governance Program Manager Lauren Kaye. The piece, titled “An early pipeline framework for assessing vendor AI solutions to support return on investment,” outlines a structured approach for evaluating AI tools in healthcare environments.

The article introduces a four-pronged framework focused on strategic alignment, business case development, risk assessment, and structured selection. The model is designed to support health systems in making more accountable, ROI-informed decisions about the adoption of third-party AI solutions.

As the pace of AI adoption accelerates across healthcare, the need for practical governance models continues to grow. The article provides system leaders with a methodology to evaluate AI investments beyond pilot phases and align technology decisions with enterprise-level goals.

Read the full article in Nature.